ArticleIranian journal of basic medical sciences2025

Dapagliflozin improves diabetic cardiomyopathy by suppressing the STAT3-YY1 signaling axis in cardiac fibroblasts.

Xing-Yi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.